| Literature DB >> 22045173 |
Scott E Delacroix1, Brian F Chapin, Christopher G Wood.
Abstract
The role of lymph node dissection (LND) in the staging and treatment of renal cell carcinoma has long been a topic of debate. The controversy has focused on whether LND is purely an adjunctive staging procedure or has a therapeutic role in the management of this disease. Potential benefits include enhanced staging, better selection for adjuvant therapies/clinical trials, a decrease in recurrence rates, and improved disease-specific and overall survival. This article reviews the available literature on LND in renal cell carcinoma and discusses the potential benefits of aggressive surgical resection in select high-risk patients. Copyright ÂEntities:
Mesh:
Year: 2011 PMID: 22045173 DOI: 10.1016/j.ucl.2011.07.008
Source DB: PubMed Journal: Urol Clin North Am ISSN: 0094-0143 Impact factor: 2.241